drugset / Trial / NCT04560283
HYDEAL-D® Application for Promoting the Restoration of Sexual Function in the Postpartum Period
RandomizedParallel-groupOpen-labelTreatment
Summary
During postpartum and lactation, vaginal epithelium tends to have an impaired degree of hydration and lubrication. This may lead to vaginal dryness, burning sensation dyspareunia or itching, which negatively affect the sexual function of puerperal women. This study aimed to evaluate the efficacy of HYDEAL-D® vaginal gel (HYALOGYN®, Fidia Farmaceutici, Abano Terme, Italy) application on promoting the restoration of sexual function in the postpartum period.
Timeline
- Start
- 2016-09-01
- Primary completion
- 2020-05-01
- Completion
- 2020-09-01
Outcome
Met primary endpoint
paper FSFI) total score (+15.1 ± 11.9 vs +6.5 ± 8.9, p < 0.001) PMID 34477473 ↗
paper the results of our study demonstrated that hyaluronic acid derivative vaginal gel (Hydeal-D) was able to improve sexual function PMID 34477473 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HYALOGYN | Other / unclassified | 2 % | Other |